About Excel Venture Management
Excel Venture Management is a venture capital firm founded in 2007. It is primarily based out of Boston, United States. As of Sep 2023, Excel Venture Management has invested in 50 companies. It primarily invests in Series B round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to HealthTech and High Tech. Most recently it led the $11.8M Series A round of NeoSensory along with Tao Capital Partners. This round also saw participation from True Ventures and other investors.
Overall, Excel Venture Management portfolio has seen 4 IPOs and 25 acquisitions including key companies like TransMedics, Exact Sciences and Mtem. A lot of funds co-invest with Excel Venture Management, with names like Healthcare Ventures sharing a substantial percentage of its portfolio.
Excel Venture Management has team of 16 people including 3 partners.
Key Metrics
Team Members
, &
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Series B &
Portfolio IPOs
Portfolio Acquisitions
Excel Venture Management's List of Top Investments
Excel Venture Management has a portfolio of 50 companies. Their most notable investments are in Snaptic and Springleaf Therapeutics.Their portfolio spans across United States, United Kingdom and Canada. They have invested in Life Sciences, HealthTech, High TechÌý²¹²Ô»å 9 other sectors, across stages such as Series A, Series B Ìý²¹²Ô»å 3 more. Here is the list of top investments by Excel Venture Management:1. TransMedics
Developer of organ transplantation technology. The company has developed the Organ Care System (OCS), an organ transplant technology that maintains organs in a living functioning state outside the body to provide. The system consists of a portable platform with a wireless monitor, a perfusion module specific to the organ, and a solution set. They have made OCS for the heart, lungs, and liver. Commercially available in Europe and Australia.
Key facts about TransMedics
- Founded Year: 1998
- Location: Andover (United States)
- Annual Revenue: $242M as on Dec 31, 2023
- Stage: Public
- Total Funding till date: $266M
- Employee Count: 584 as on Dec 31, 2023
- Investors: LanceBio Ventures, Hercules Capital and 19 Others
- Latest Funding Round: Conventional Debt, Sep 15, 2022, $60M
- Highlight: Public
2. Welldoc
WellDoc’s flagship product, BlueStar, is a Mobile Prescription Therapy that enables patients to self-manage their diabetes through real-time motivational, behavioral, and educational coaching. Personalized coaching is provided using patented algorithms and real-time analysis of patient diabetes data. BlueStar requires a prescription from a licensed healthcare provider and can be dispensed and reimbursed through a pharmacy.
Key facts about Welldoc
- Founded Year: 2005
- Location: Columbia (United States)
- Stage: Series B
- Total Funding till date: $72.1M
- Employee Count: 65 as on Dec 31, 2022
- Investors: Adage Capital Management, Hudson River Capital Partners and 13 Others
- Latest Funding Round: Series B, Mar 01, 2016, $7.5M
- Highlight: Editors' Pick
3. Foodsmart
Provider of telenutrition and food care network platform. The platform provides users with health plans. The platform provides telenutrition meetings with registered dietitians. It also provides personalized meal plans and recipes.
Key facts about Foodsmart
- Founded Year: 2010
- Location: San Francisco (United States)
- Stage: Series D
- Total Funding till date: $263M
- Employee Count: 73 as on Dec 31, 2020
- Investors: Seventure Partners, Excel Venture Management and 26 Others
- Latest Funding Round: Series D, Jun 26, 2024, $200M
- Highlight: Editors' Pick
Provider of non-invasive molecular diagnostic testing solutions for cancer. The flagship product includes Cologuard is intended for the qualitative detection of colorectal neoplasia-associated DNA markers and for the presence of occult hemoglobin in human stool to estimate a patient's risk of developing colorectal cancer. Also, it offers an MCED blood test for multi-cancer detection.
Key facts about Exact Sciences
- Founded Year: 1995
- Location: Madison (United States)
- Annual Revenue: $2.5B as on Dec 31, 2023
- Stage: Public
- Employee Count: 6,600 as on Dec 31, 2023
- Investors: Great Point Partners, Bank of America and 8 Others
- Latest Funding Round: Post IPO, Mar 08, 2019, $748M
- Highlight: Public
5. Mtem
Developer of next-gen immunotoxins for cancer. The proprietary platform technology is based on Engineered Toxin Bodies, which are comprised of an antibody fragment (the binding domain) and an engineered toxin scaffold. ETBs are designed to inactivate ribosomes and thereby protein synthesis and are also engineered to be less immunogenic than traditional antibody-drug conjugates, The company's lead candidate for non-Hodgkin's lymphoma, multiple myeloma, breast cancer, and melanoma.
Key facts about Mtem
- Founded Year: 2004
- Location: Edinburgh (United Kingdom)
- Annual Revenue: $13.3M as on Dec 31, 2018
- Stage: Acquired
- Total Funding till date: $13.7M
- Investors: BB Biotech, Frazier Healthcare Partners and 11 Others
- Latest Funding Round: Post IPO, Jul 26, 2023, $20M
- Highlight: Acquired
Excel Venture Management's Year-on-Year Investment Trends
Excel Venture Management has invested in 50 companies over the last 16 years, with an average of 1 new investment annually in the last 10 years. Its most recent first time investment was in NeoSensory and most recent follow-on round was in InfoBionic.
Get Excel Venture Management's portfolio delivered to your inbox!
Excel Venture Management's Investments by Stage
Excel Venture Management has made 11 investments in Series A stage with an average round size of $5.15M, 8 investments in Series B stage with an average round size of $14.3M, 3 investments in Seed stage with an average round size of $2.3M, 3 investments in Series C stage with an average round size of $15.5M and 1 investment in Series D stage with an average round size of $40M.Note: We have considered here, only first round of investments
Stage of entry | No. of Investments |
|---|---|
Series A | 11 |
Series B | 8 |
Seed | 3 |
Series C | 3 |
Series D | 1 |
Excel Venture Management's Investments by Sector
Excel Venture Management has a diverse portfolio, with companies operating in the Life Sciences, HealthTech, Enterprise Applications, High Tech and Vertical SaaS. Notably, it has invested in 36 Tech companies, 35 Enterprise (B2B) companies, 10 Software companies and at least 8 companies focusing on Saas.
Note: We have considered here, only first round of investments
Sector | No. of Investments |
|---|---|
Life Sciences | 14 |
HealthTech | 8 |
Enterprise Applications | 7 |
High Tech | 6 |
Vertical SaaS | 4 |
Others | 15 |
Excel Venture Management's Investments by Geography
Excel Venture Management has made most investments in United States (23), followed by Canada where it has made 1 investment.
Note: We have considered here, only first round of investments
Country | No. of Investments |
|---|---|
United States | 23 |
Canada | 1 |
United Kingdom | 1 |
Excel Venture Management's recent investments
Here are the most recent investments by Excel Venture Management:
Date | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Sep 29, 2023 | United States | Series D | $57.8M | Mayo Clinic [+4] | |
May 01, 2020 | Canada | Series B | $5.4M | Baxter [+3] | |
Jan 02, 2019 | United States | Series A | $11.8M | DigiTx Partners [+2] | |
Nov 19, 2018 | United States | Series C | $26M | Humana [+6] | |
Sep 11, 2018 | United States | Series C | $50M |
Get the detailed list of all investments by Excel Venture Management. Download now!IPOs and Publicly Listed companies in Excel Venture Management's Portfolio
Here are Excel Venture Management's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
May 02, 2019 | - | - | - | |
Jun 30, 2017 | Jun 08, 2009 | Series D | $40M | |
Aug 05, 2016 | - | - | - | |
Feb 12, 2001 | - | - | - |
Acquired companies in Excel Venture Management's Portfolio
Here are Excel Venture Management's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
 | Oct 31, 2022 | - | - | - |
Jun 24, 2020 | - | - | - | |
May 01, 2020 | Oct 05, 2012 | Series C | $28M | |
Jan 07, 2019 | Jul 21, 2016 | Series B | $7M | |
Oct 19, 2017 | Aug 22, 2011 | Series B | $18.4M |
Team profile of Excel Venture Management
Excel Venture Management has a team of 16 membersÌýincluding 3 PartnersÌýlocated in United States and China. Excel Venture Management's team does not sit on the board of any company as of now.Here is a list of top team members in Excel Venture Management:
Name | Designation | Location | Board Memberships | Contact details |
|---|---|---|---|---|
Partner | Boston | - | - | |
Partner | Boston | - | - | |
Partner | Boston | - | - | |
Advisor | Salt Lake City | - | - | |
Advisor | Westfield | - | - | |
Advisor | United States | - | - | |
Advisor | Winston-salem | - | - | |
Advisor | - | - | - | |
Advisor | Hong Kong | - | - | |
Advisor | - | - | - | |
Advisor | - | - | - |
Get the full list of Excel Venture Management's team & partners for free. Download now!Co-investors of Excel Venture Management
Over the past 16 years, 118 investors have co-invested in Excel Venture Management's portfolio companies.
- Invested before Excel Venture Management:Ìý, Merck Global Health Innovation Fund and 24 others have invested in rounds before Excel Venture Management. There are 1 company where Windham Venture Partners has invested before Excel Venture Management and 1 company where Merck Global Health Innovation Fund has invested before Excel Venture Management.
- Top Co-investors of Excel Venture Management:Ìý44 investors entered a company along with Excel Venture Management. These include investors like Healthcare Ventures (3 companies).
- Invested after Excel Venture Management:ÌýA total of 48 investors have invested in Excel Venture Management's portfolio after their investments. Top Investors include Blue Cross Blue Shield of Massachusetts (2 companies), Ascension Ventures (2 companies) and Samsung Venture Investment (1 company).
Get full list of Excel Venture Management's co-investors delivered to your inbox!
Recent News related to Excel Venture Management
•
Medical Product Outsourcing•Jan 09, 2024•InfoBionic, Mayo Clinic, Excel Venture Management, Blue Cross Blue Shield of Massachusetts
•
•
BetaKit•May 01, 2020•Ayogo Health, Baxter, MEDTEQ, Merck Global Health Innovation Fund and 2 others
•
PR Newswire•Jan 09, 2019•NeoSensory, Excel Venture Management, DigiTx Partners, True Ventures and 1 other
•
Business Wire•Nov 19, 2018•ClearDATA, Flare Capital Partners, HLM Venture Partners, Excel Venture Management and 5 others
•
Business Wire•Sep 11, 2018•InfoBionic, Eagle Investment Systems, Excel Venture Management, Safeguard Scientifics and 3 others
•
•
•
Citybizlist•Apr 13, 2017•ClearDATA, Merck Global Health Innovation Fund, Norwest Venture Partners, Excel Venture Management and 3 others
•
VCA Online•Dec 01, 2016•Qstream, Polaris Partners, Frontline Ventures, Launchpad Venture Group and 1 other
